• 1
    IARC Monographs on the Evaluation of Carcinogenic Risks in Humans. Vol. 59. Hepatitis Viruses. Lyon: International Agency for Research on Cancer, 1994: 45221.
  • 2
    Simons JN, Leary TP, Dawson GJ, Pilot-Mathias TJ, Muerhoff AS, Schlauderr GG, Desai SM, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564569.
  • 3
    Linnen J, Wages J Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissable agent. Science 1996; 271: 505508.
  • 4
    Alter HJ. The cloning and clinical implications of HGV and GBV-C. N Engl J Med 1996; 334: 15361537.
  • 5
    Masuko M, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, et al. Infection with hepatitis GB virus-C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 14851490.
  • 6
    Alter MJ, Gallagher M, Morris T, Moyer L, Krawczynski K, Khudyakov Y, Fields H, et al. Epidemiology of non-A, non-B hepatitis. In: Rizzetto M, ed. Proceedings of the Ninth Triennial International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996, in press.
  • 7
    Yoshibo M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown origin. Lancet 1995; 346: 11311134.
  • 8
    Nubling CM, Lower J. GB-C genomes in a high risk group, in plasma pools, and in intravenous immunoglobulin. Lancet 1996; 347: 68.
  • 9
    Kudo T, Morishima T, Tsuzuki K, Orito E, Mizokami M. Hepatitis G virus in immunosuppressed pediatric allograft recipients [Letter]. Lancet 1996; 348: 751.
  • 10
    Neilson J, Harrison P, Milligan DW, Skidmore SJ, Collingham KE. Hepatitis G in long-term survivors of hematological malignancy. Lancet 1996; 347: 16321633.
  • 11
    Feucht H-H, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G [Letter]. Lancet 1996; 347: 615.
  • 12
    Kew MC, Yu MC, Kedda M-A, Coppin A, Sarkin A, Hodkinson J. The relative role of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997; 112: 184187.
  • 13
    Bukh J, Miller RH, Purcell RH. Importance of primer selection for the detection of hepatitis C virus RNA in the polymerase chain reaction assay. Proc Natl Acad Sci U S A 1992; 89: 187191.
  • 14
    Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 1–The Analysis of Case-Control Studies. No.32. Lyon, France: IARC Scientific Publications, 1980: 248279.
  • 15
    Kew MC, McKnight A, Hodkinson J, Bukofzer S, Esser JD. The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in southern African blacks. Hepatology 1989; 9: 121125.
  • 16
    Ozturk M, Puisieux A, Kew MC, Volkman M, Bozcall S, Mura JB, de la Monte S, et al. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338: 13561358.
  • 17
    Fiordalisi G, Zanella I, Mantero G, Bettinardi A, Stellini R, Paraninfo G, Cadeo G, et al. High prevalence of GB Virus-C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis 1996; 174: 181183.
  • 18
    Dawson GJ, Schlauder GG, Pitot-Matias T-J, Thiele D, Leary TP, Murphy P, Rosenblatt JE, et al. Prevalence studies of GB Virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol 1996; 50: 97103.
  • 19
    Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 4: 136146.
  • 20
    Kew MC. Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev 1994; 14: 211220.